Gilead Sciences
GILD
#131
Rank
S$207.22 B
Marketcap
S$166.91
Share price
-0.82%
Change (1 day)
12.08%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): S$13.76 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are S$29.73 Billion. In 2025 the company made an earning of S$12.55 Billion, an increase over its 2024 earnings that were of S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$13.76 B9.62%
2025 S$12.55 B1319.86%
2024 S$0.88 B-89.94%
2023 S$8.79 B17.97%
2022 S$7.45 B-29.77%
2021 S$10.61 B395.99%
2020 S$2.13 B-67.66%
2019 S$6.61 B-33.84%
2018 S$9.99 B-42.35%
2017 S$17.34 B-20.87%
2016 S$21.91 B-21.06%
2015 S$27.76 B45.8%
2014 S$19.04 B253.01%
2013 S$5.39 B16.51%
2012 S$4.62 B-1.07%
2011 S$4.67 B-6.71%
2010 S$5.01 B11.75%
2009 S$4.48 B29.5%
2008 S$3.46 B19.11%
2007 S$2.91 B-455.74%
2006 -S$0.82 Billion-154.93%
2005 S$1.48 B76.99%
2004 S$0.84 B-266.16%
2003 -S$0.51 Billion-638.24%
2002 S$94.08 M31.5%
2001 S$71.54 M-242.15%
2000 -S$50.34 Million-40.2%
1999 -S$84.17 Million31.85%
1998 -S$63.84 Million8.73%
1997 -S$58.71 Million27.22%
1996 -S$46.15 Million
1994 -S$43.97 Million26.57%
1993 -S$34.74 Million46.49%
1992 -S$23.72 Million362.5%
1991 -S$5.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.30 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.57 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.65 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.89 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.64 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.08 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.48 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.48 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.85 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA